TY - JOUR
T1 - Oxoplatin-Based Pt(IV) Lipoate Complexes and Their Biological Activity
AU - Liu, Xiao
AU - Barth, Marie Christin
AU - Cseh, Klaudia
AU - Kowol, Christian R.
AU - Jakupec, Michael A.
AU - Keppler, Bernhard K.
AU - Gibson, Dan
AU - Weigand, Wolfgang
N1 - Publisher Copyright:
© 2022 The Authors. Chemistry & Biodiversity published by Wiley-VHCA AG, Zurich, Switzerland.
PY - 2022/10
Y1 - 2022/10
N2 - α-Lipoic acid, known for its anti-inflammatory and antioxidant activity, represents a promising ligand for Pt(IV) prodrugs. Three new Pt(IV) lipoate complexes were synthesized and characterized by NMR spectroscopy (1H, 13C, 195Pt), mass spectrometry and elemental analysis. Due to the low solubility of the complex containing two axial lipoate ligands, further experiments to examine the biological activity were performed with two Pt(IV) complexes containing just one axial lipoate ligand. Both complexes exhibit anticancer activity and produce reactive oxygen species (ROS) in the cell lines tested. Especially, the monosubstituted complex can be reduced by ascorbic acid and forms adducts with 9-methylguanine (9MeG), which is favorable for the formation of DNA-crosslinks in the cells.
AB - α-Lipoic acid, known for its anti-inflammatory and antioxidant activity, represents a promising ligand for Pt(IV) prodrugs. Three new Pt(IV) lipoate complexes were synthesized and characterized by NMR spectroscopy (1H, 13C, 195Pt), mass spectrometry and elemental analysis. Due to the low solubility of the complex containing two axial lipoate ligands, further experiments to examine the biological activity were performed with two Pt(IV) complexes containing just one axial lipoate ligand. Both complexes exhibit anticancer activity and produce reactive oxygen species (ROS) in the cell lines tested. Especially, the monosubstituted complex can be reduced by ascorbic acid and forms adducts with 9-methylguanine (9MeG), which is favorable for the formation of DNA-crosslinks in the cells.
KW - cyclovoltammetry
KW - lipoic acid
KW - multi-action
KW - Pt(IV) prodrugs
KW - ROS
UR - http://www.scopus.com/inward/record.url?scp=85138300768&partnerID=8YFLogxK
U2 - 10.1002/cbdv.202200695
DO - 10.1002/cbdv.202200695
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 36026613
AN - SCOPUS:85138300768
SN - 1612-1872
VL - 19
JO - Chemistry and Biodiversity
JF - Chemistry and Biodiversity
IS - 10
M1 - e202200695
ER -